Concepedia

Publication | Open Access

A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma

DOIFull Paper Access

26

Citations

45

References

2018

Year

Shunsuke Shibao, Ryo Ueda, Katsuya Saito, Ryogo Kikuchi, Hideaki Nagashima, Atsuhiro Kojima, Hiroshi KAGAMI, Eriel Sandika Pareira, Hikaru Sasaki, Shinobu Noji,
Oncotarget

Abstract

These data demonstrate the safety and immunogenicity of VEGFR peptide vaccines targeting tumor vasculatures in high grade gliomas.

References

YearCitations

Page 1